Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine.
D000152:Acne Vulgaris / Q000139:chemically induced; D000308:Adrenocortical Hyperfunction / Q000139:chemically induced; D000974:Antibodies, Antinuclear / Q000032:analysis; D001379:Azathioprine / Q000627:therapeutic use*; D003165:Complement System Proteins / Q000032:analysis; D003404:Creatinine / Q000097:blood / Q000652:urine; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007958:Leukocyte Count; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000276:immunology; D009393:Nephritis / Q000188:drug therapy* / Q000209:etiology; D009404:Nephrotic Syndrome / Q000209:etiology; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use*; D011507:Proteinuria; D012008:Recurrence
D000974:Antibodies, Antinuclear; D003165:Complement System Proteins; D003404:Creatinine; D001379:Azathioprine; D011241:Prednisone